Cargando…

Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease

The large majority of neuroimaging studies in Alzheimer’s disease (AD) patients have supported the idea that lifestyle factors may protect against the clinical manifestations of AD rather than influence AD neuropathological processes (the cognitive reserve hypothesis). This evidence argues in favor...

Descripción completa

Detalles Bibliográficos
Autores principales: Arenaza-Urquijo, Eider M., Wirth, Miranka, Chételat, Gaël
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530312/
https://www.ncbi.nlm.nih.gov/pubmed/26321944
http://dx.doi.org/10.3389/fnagi.2015.00134
_version_ 1782384895325110272
author Arenaza-Urquijo, Eider M.
Wirth, Miranka
Chételat, Gaël
author_facet Arenaza-Urquijo, Eider M.
Wirth, Miranka
Chételat, Gaël
author_sort Arenaza-Urquijo, Eider M.
collection PubMed
description The large majority of neuroimaging studies in Alzheimer’s disease (AD) patients have supported the idea that lifestyle factors may protect against the clinical manifestations of AD rather than influence AD neuropathological processes (the cognitive reserve hypothesis). This evidence argues in favor of the hypothesis that lifestyle factors act as moderators between AD pathology and cognition, i.e., through indirect compensatory mechanisms. In this review, we identify emerging evidence in cognitively normal older adults that relate lifestyle factors to established AD neuroimaging biomarkers. While some of these investigations are in agreement with the compensatory view of cognitive reserve, other studies have revealed new clues on the neural mechanisms underlying beneficial effects of lifestyle factors on the brain. Specifically, they provide novel evidence suggesting direct effects of lifestyle factors on AD neuropathological processes. We propose a tentative theoretical model where lifestyle factors may act via direct neuroprotective and/or indirect compensatory mechanisms. Importantly, we suggest that neuroprotective mechanisms may have a major role during early stages and compensatory mechanisms in later stages of the disease. In the absence of an effective treatment for AD and considering the potential of lifestyle factors in AD prevention, understanding the neural mechanisms underlying lifestyle effects on the brain seems crucial. We hope to provide an integrative view that may help to better understand the complex effects of lifestyle factors on AD neuropathological processes, starting from the preclinical stage.
format Online
Article
Text
id pubmed-4530312
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-45303122015-08-28 Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease Arenaza-Urquijo, Eider M. Wirth, Miranka Chételat, Gaël Front Aging Neurosci Neuroscience The large majority of neuroimaging studies in Alzheimer’s disease (AD) patients have supported the idea that lifestyle factors may protect against the clinical manifestations of AD rather than influence AD neuropathological processes (the cognitive reserve hypothesis). This evidence argues in favor of the hypothesis that lifestyle factors act as moderators between AD pathology and cognition, i.e., through indirect compensatory mechanisms. In this review, we identify emerging evidence in cognitively normal older adults that relate lifestyle factors to established AD neuroimaging biomarkers. While some of these investigations are in agreement with the compensatory view of cognitive reserve, other studies have revealed new clues on the neural mechanisms underlying beneficial effects of lifestyle factors on the brain. Specifically, they provide novel evidence suggesting direct effects of lifestyle factors on AD neuropathological processes. We propose a tentative theoretical model where lifestyle factors may act via direct neuroprotective and/or indirect compensatory mechanisms. Importantly, we suggest that neuroprotective mechanisms may have a major role during early stages and compensatory mechanisms in later stages of the disease. In the absence of an effective treatment for AD and considering the potential of lifestyle factors in AD prevention, understanding the neural mechanisms underlying lifestyle effects on the brain seems crucial. We hope to provide an integrative view that may help to better understand the complex effects of lifestyle factors on AD neuropathological processes, starting from the preclinical stage. Frontiers Media S.A. 2015-08-10 /pmc/articles/PMC4530312/ /pubmed/26321944 http://dx.doi.org/10.3389/fnagi.2015.00134 Text en Copyright © 2015 Arenaza-Urquijo, Wirth and Chételat. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neuroscience
Arenaza-Urquijo, Eider M.
Wirth, Miranka
Chételat, Gaël
Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease
title Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease
title_full Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease
title_fullStr Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease
title_full_unstemmed Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease
title_short Cognitive reserve and lifestyle: moving towards preclinical Alzheimer’s disease
title_sort cognitive reserve and lifestyle: moving towards preclinical alzheimer’s disease
topic Neuroscience
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4530312/
https://www.ncbi.nlm.nih.gov/pubmed/26321944
http://dx.doi.org/10.3389/fnagi.2015.00134
work_keys_str_mv AT arenazaurquijoeiderm cognitivereserveandlifestylemovingtowardspreclinicalalzheimersdisease
AT wirthmiranka cognitivereserveandlifestylemovingtowardspreclinicalalzheimersdisease
AT chetelatgael cognitivereserveandlifestylemovingtowardspreclinicalalzheimersdisease